NEW YORK / Sep 28, 2023 / Business Wire / Talkspace (NASDAQ: TALK) – a leading online behavioral health company – was today named by Crain’s New York Business as one of the publication’s “2023 Best Places to Work.”
The annual list recognizes 100 small, medium, and large companies headquartered in New York City who are offering their employees an exceptional experience, whether in-office or remotely. Selections are based on extensive employee surveys and audits of benefits, human resources, policies, and perks.
“Talkspace is proud to be recognized by a revered New York institution such as Crain’s, alongside high performing companies who share similar values. Empathy, kindness, and belonging are at the core of our culture, especially as we are entrusted by employers nationwide with high quality mental health solutions for their employees,” said Andrea Cooper, Chief People Officer of Talkspace.
Talkspace offers its full-time employees generous PTO, choice of flexible hybrid or remote-only work, wellness stipends, retirement benefits, comprehensive medical plans, and free access to Talkspace’s comprehensive suite of mental health products.
About Talkspace
Talkspace (Nasdaq: TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone. Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.
All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covers approximately 110 million lives as of June 30, 2023, through our partnerships with employers, health plans, and paid benefits programs.
Last Trade: | US$3.09 |
Daily Change: | -0.17 -5.21 |
Daily Volume: | 1,299,594 |
Market Cap: | US$521.960M |
December 10, 2024 October 29, 2024 September 04, 2024 August 06, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB